Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries
Feasibility Study of Phase-contrast MRI for Flow in the External Carotid Branches Arteries in Normal and Pathological Cases
Centre Hospitalier Universitaire, Amiens
80 participants
Jan 6, 2014
INTERVENTIONAL
Conditions
Summary
The phase-contrast MRI offers the advantage to combine precisely vascular flow measurements data with morphological images. Even if the anatomy of the external carotid artery is well known, data obtained through Phase contrast MRI could permit to progress in several fields of cranio-maxillofacial surgery as for example arteriovenous malformations,radionecrosis, head and neck micro-reconstructive surgery. The aim of this study is to establish and develop Phase-contrast MRI sequences for vascular flow characterization branches of the external carotid artery in healthy patients and in pathological cases.
Eligibility
Inclusion Criteria5
- group 1 : healthy volunteer
- group 2 : X-Ray treatment antecedent (at least 50 grays and older than one year)
- group 3 : antecedent of embolization of branches of external carotid artery
- group 4 : antecedent of muscular free flap surgery (older than one month)
- free and informed consent
Exclusion Criteria7
- group 1 : facial pathology, antecedent of facial injury, antecedent of X-Ray treatment in head and neck localisation, antecedent of head and neck cancer
- group 2 : antecedent of surgery for head and neck cancer or for vascular disease
- group 3 : antecedent of surgery for head and neck cancer or for vascular disease ; antecedent of X-Ray treatment.
- group 4 : antecedent of surgery for head and neck cancer or for vascular disease ; antecedent of X-Ray treatment or embolization
- patient with guardianship or trusteeship
- MRI cons-indications
- pregnancy and lactation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Magnetic Resonance Imaging (MRI) of flow using phase contrast (PC) methods
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02829190